News Image

While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable.

By Mill Chart

Last update: May 10, 2024

Uncover the potential of CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a growth stock that our stock screener found to be reasonably priced. NASDAQ:CORT is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation. We'll examine each aspect in detail.

Growth Assessment of NASDAQ:CORT

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:CORT scores a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 29.27% over the past year.
  • Looking at the last year, CORT shows a very strong growth in Revenue. The Revenue has grown by 26.48%.
  • The Revenue has been growing by 13.94% on average over the past years. This is quite good.
  • Based on estimates for the next years, CORT will show a very strong growth in Earnings Per Share. The EPS will grow by 28.00% on average per year.
  • Based on estimates for the next years, CORT will show a quite strong growth in Revenue. The Revenue will grow by 16.69% on average per year.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Understanding NASDAQ:CORT's Valuation Score

ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NASDAQ:CORT was assigned a score of 6 for valuation:

  • CORT's Price/Earnings ratio is rather cheap when compared to the industry. CORT is cheaper than 83.59% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CORT indicates a rather cheap valuation: CORT is cheaper than 83.59% of the companies listed in the same industry.
  • CORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CORT is cheaper than 80.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CORT is valued cheaper than 82.56% of the companies in the same industry.
  • The excellent profitability rating of CORT may justify a higher PE ratio.
  • CORT's earnings are expected to grow with 29.87% in the coming years. This may justify a more expensive valuation.

Health Insights: NASDAQ:CORT

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:CORT has received a 9 out of 10:

  • An Altman-Z score of 17.72 indicates that CORT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 17.72, CORT belongs to the top of the industry, outperforming 91.79% of the companies in the same industry.
  • There is no outstanding debt for CORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • CORT has a Current Ratio of 5.18. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.18, CORT is in the better half of the industry, outperforming 67.18% of the companies in the same industry.
  • CORT has a Quick Ratio of 5.10. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 5.10, CORT is in the better half of the industry, outperforming 67.69% of the companies in the same industry.

Assessing Profitability for NASDAQ:CORT

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:CORT, the assigned 8 is a significant indicator of profitability:

  • With an excellent Return On Assets value of 17.99%, CORT belongs to the best of the industry, outperforming 97.44% of the companies in the same industry.
  • The Return On Equity of CORT (21.54%) is better than 93.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 18.83%, CORT belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CORT is significantly above the industry average of 16.49%.
  • The Profit Margin of CORT (22.54%) is better than 94.36% of its industry peers.
  • The Operating Margin of CORT (23.30%) is better than 91.28% of its industry peers.
  • Looking at the Gross Margin, with a value of 98.55%, CORT belongs to the top of the industry, outperforming 99.49% of the companies in the same industry.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of CORT

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (12/27/2024, 4:30:00 PM)

After market: 52.47 0 (0%)

52.47

-1.16 (-2.16%)

Follow us for more